Deutsche Bank Ag\ Apellis Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$287 Billion
Q3 2025

A detailed history of Deutsche Bank Ag\ transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 1,504,457 shares of APLS stock, worth $30.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,504,457

Previous 1,496,296 0.55%

Holding current value

$30.6 Million

Previous $25.9 Million 31.45%

% of portfolio

0.01%

Previous 0.01%

39 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$17.42 - $28.65 $142,164 - $233,812	8,161 Added 0.55%	1,504,457 $34 Million
Q2 2025 Aug 12, 2025	SELL	$16.36 - $23.0 $4.59 Million - $6.45 Million	-280,280 Reduced 15.78%	1,496,296 $25.9 Million
Q1 2025 May 09, 2025	SELL	$21.87 - $34.63 $39,387 - $62,368	-1,801 Reduced 0.1%	1,776,576 $38.9 Million
Q4 2024 Jun 30, 2025	BUY	$26.18 - $35.42 $47,150 - $63,791	1,801 Added 0.1%	1,778,377 $56.7 Million
Q4 2024 Feb 14, 2025	BUY	$26.18 - $35.42 $808,098 - $1.09 Million	30,867 Added 1.77%	1,778,377 $56.7 Million

Q3 2024 Jun 26, 2025	SELL	$28.84 - $41.15 $838,263 - $1.2 Million	-29,066 Reduced 1.64%	1,747,510 $50.4 Million
Q3 2024 Nov 13, 2024	SELL	$28.84 - $41.15 $2.73 Million - $3.89 Million	-94,532 Reduced 5.13%	1,747,510 $50.4 Million
Q2 2024 Jun 12, 2025	BUY	$38.07 - $59.71 $2.49 Million - $3.91 Million	65,466 Added 3.68%	1,842,042 $70.7 Million
Q2 2024 Aug 14, 2024	BUY	$38.07 - $59.71 $8.77 Million - $13.7 Million	230,269 Added 14.29%	1,842,042 $70.7 Million
Q1 2024 Jun 02, 2025	SELL	$55.39 - $72.47 $9.13 Million - $11.9 Million	-164,803 Reduced 9.28%	1,611,773 $94.7 Million
Q1 2024 May 15, 2024	BUY	$55.39 - $72.47 $41.8 Million - $54.7 Million	754,774 Added 88.07%	1,611,773 $94.7 Million
Q4 2023 Feb 14, 2024	BUY	$37.14 - $64.82 $19.8 Million - $34.5 Million	532,705 Added 164.27%	856,999 $51.3 Million
Q3 2023 Nov 09, 2023	SELL	$23.65 - $89.22 $3.64 Million - $13.7 Million	-154,072 Reduced 32.21%	324,294 $12.3 Million
Q2 2023 Aug 14, 2023	SELL	$76.68 - $93.31 $9.28 Million - $11.3 Million	-121,062 Reduced 20.2%	478,366 $43.6 Million
Q1 2023 May 15, 2023	BUY	$46.59 - $66.96 $15.7 Million - $22.5 Million	336,251 Added 127.77%	599,428 $39.5 Million
Q4 2022 Feb 13, 2023	SELL	$43.24 - $61.04 $13.2 Million - $18.6 Million	-304,568 Reduced 53.65%	263,177 $13.6 Million
Q3 2022 Nov 14, 2022	SELL	$44.76 - $69.66 $5.68 Million - $8.84 Million	-126,862 Reduced 18.26%	567,745 $38.8 Million
Q2 2022 Aug 11, 2022	BUY	$35.07 - $59.21 $5.27 Million - $8.9 Million	150,296 Added 27.61%	694,607 $31.4 Million
Q1 2022 May 13, 2022	BUY	$35.46 - $54.12 $7.29 Million - $11.1 Million	205,558 Added 60.68%	544,311 $27.7 Million
Q4 2021 Feb 11, 2022	BUY	$30.74 - $49.16 $1.47 Million - $2.35 Million	47,744 Added 16.41%	338,753 $16 Million
Q3 2021 Nov 04, 2021	SELL	$31.4 - $69.84 $909,092 - $2.02 Million	-28,952 Reduced 9.05%	291,009 $9.59 Million
Q2 2021 Aug 11, 2021	SELL	$40.9 - $64.9 $4.08 Million - $6.47 Million	-99,699 Reduced 23.76%	319,961 $20.2 Million
Q1 2021 May 13, 2021	SELL	$40.8 - $57.39 $8.73 Million - $12.3 Million	-214,077 Reduced 33.78%	419,660 $18 Million
Q4 2020 Feb 16, 2021	BUY	$30.79 - $57.2 $2.36 Million - $4.38 Million	76,506 Added 13.73%	633,737 $36.3 Million
Q3 2020 Nov 12, 2020	BUY	$25.89 - $33.65 $314,408 - $408,645	12,144 Added 2.23%	557,231 $16.8 Million
Q2 2020 Aug 13, 2020	BUY	$24.8 - $38.49 $8.92 Million - $13.8 Million	359,645 Added 193.94%	545,087 $17.8 Million
Q1 2020 May 14, 2020	BUY	$17.91 - $44.33 $365,937 - $905,750	20,432 Added 12.38%	185,442 $4.97 Million
Q4 2019 Feb 14, 2020	BUY	$22.1 - $30.8 $756,858 - $1.05 Million	34,247 Added 26.19%	165,010 $5.05 Million
Q3 2019 Nov 14, 2019	BUY	$24.09 - $32.18 $395,051 - $527,719	16,399 Added 14.34%	130,763 $3.15 Million
Q2 2019 Aug 14, 2019	SELL	$18.0 - $25.34 $236,736 - $333,271	-13,152 Reduced 10.31%	114,364 $2.9 Million
Q1 2019 May 15, 2019	BUY	$12.81 - $19.82 $1.3 Million - $2.01 Million	101,431 Added 388.85%	127,516 $2.49 Million
Q4 2018 Feb 14, 2019	SELL	$11.47 - $18.71 $1.13 Million - $1.85 Million	-98,833 Reduced 79.12%	26,085 $343,000
Q3 2018 Dec 21, 2021	BUY	$16.57 - $21.03 $861,292 - $1.09 Million	51,979 Added 71.26%	124,918 $2.22 Million
Q3 2018 Nov 14, 2018	BUY	$16.57 - $21.03 $49,991 - $63,447	3,017 Added 4.31%	72,939 $1.3 Million
Q2 2018 Apr 21, 2020	BUY	$19.63 - $30.0 $244,334 - $373,410	12,447 Added 21.66%	69,922 $1.54 Million
Q2 2018 Aug 14, 2018	BUY	$19.63 - $30.0 $845,876 - $1.29 Million	43,091 Added 299.58%	57,475 $1.26 Million
Q1 2018 Oct 18, 2019	BUY	$14.01 - $26.02 $35,445 - $65,830	2,530 Added 21.34%	14,384 $317,000
Q1 2018 May 15, 2018	SELL	$14.01 - $26.02 $167,475 - $311,043	-11,954 Reduced 50.21%	11,854 $261,000
Q4 2017 Feb 14, 2018	BUY	$12.71 - $21.7 $302,599 - $516,633	23,808	23,808 $516,000

Others Institutions Holding APLS

# of Institutions

328

Shares Held

124M

Call Options Held

4.12M

Put Options Held

756K

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.23B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account